Hypersensitivity to trastuzumab, murine proteins, hyaluronidase or to any of the other excipients listed in Description.
Severe dyspnoea at rest due to complications of advanced malignancy or requiring supplementary oxygen therapy.
Sign up for Free to Continue Reading
Sign up for Free to Continue Reading